State and trait abnormalities in serotonin function in major depression

British Journal of Psychiatry

Volumn 180, Issue JAN., 2002, Pages 24-28

  Bhagwagar, Z ^a   Whale, R ^a   Cowen, P J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; HYDROCORTISONE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; ENDOCRINE FUNCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL HEALTH; NEUROTRANSMITTER RELEASE; PERSONALITY DISORDER; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE;

ACUTE DISEASE; ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0036153274     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.180.1.24     Document Type: Article

References (27)

1. Decreased 5-HT-mediated prolactin release in major depression
2. Low-dose citalopram as a 5HT neuroendocrine probe
3. An inventory for measuring depression
4. Diminished prolactin responses to repeat fenfluramine challenge in man
5. Rank transformations as a bridge between parametric and non-parametric statistics
6. Neuroendocrine challenge tests: What can we learn from them?
7. Recovery from major depression is not associated with normalisation of serotonergic function
8. Conceptualisation and rationale for consensus definitions of terms in major depressive disorder remission, recovery, relapse, and recurrence
9. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects
10. A rating scale for depression
11. Citalopram
12. The citalopram challenge test in patients with major depression and healthy controls
13. The neurobiology of impulsive aggression
14. The prediction of major depression in women: Toward an integrated etiologic model
15. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
16. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: A critical review
17. Brain serotonin IA receptor binding measured by positron emission tomography using IIC WAY 100635
18. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe
19. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients
20. Impaired regulation of brain serotonin function during dieting in women recovered from depression
21. Blunted growth hormone and prolactin response to L-tryptophan in depression: A state dependent abnormality
22. [(123)I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug free depressed patients with seasonal affective disorder
23. Brain serotonin2 receptors in major depression: A positron emission tomography study
24. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression